It’s great to finally have met everyone again in person @ CannaTrade 2022 !
The Pure highlights:
🌿the new PURE products.
🌿newest insights on the first THC pilot project in Switzerland.
🌿our leading research Puregene AG.
🌿Pure Pharma and cannabis as medicine
We also enjoyed very insightful panels:
First THC state-licensed pilot projects
Marc Brüngger our Head of Innovation & Regulation shared the stage with Barbara Burri Sharani, Sven Schendekehl, Mosimann Michael and Michael Spahr – to discuss the latest developments on the first and upcoming Swiss THC pilot-projects.
The current status of medical cannabis in Switzerland?
Andreas “Reli” Faeh CEO Pure Pharma AG was sharing the stage with Christin Glanzmann, Manfred Fankhauser, Dr Marcel Boller and Felix Iten on very important developments for medicinal cannabis at CannaTrade 2022.
We are already looking forward to Cannatrade 2023!